These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20625152)

  • 1. Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection.
    Biedenbach DJ; Castanheira M; Jones RN
    Antimicrob Agents Chemother; 2010 Sep; 54(9):4009-11. PubMed ID: 20625152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CEM-101 activity against Gram-positive organisms.
    Woosley LN; Castanheira M; Jones RN
    Antimicrob Agents Chemother; 2010 May; 54(5):2182-7. PubMed ID: 20176910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neisseria meningitidis with decreased susceptibility to penicillin: report from the SENTRY antimicrobial surveillance program, North America, 1998-99.
    Richter SS; Gordon KA; Rhomberg PR; Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 2001; 41(1-2):83-8. PubMed ID: 11687319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibilities of 55 strains of Neisseria meningitidis isolated in Spain in 1993 and 1994.
    Florez C; Garcia-Lopez JL; Martin-Mazuelos E
    Chemotherapy; 1997; 43(3):168-70. PubMed ID: 9142456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of ciprofloxacin, cefotaxime, ceftriaxone, chloramphenicol, and rifampin against fully susceptible and moderately penicillin-resistant Neisseria meningitidis.
    Blondeau JM; Yaschuk Y
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2577-9. PubMed ID: 8585750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vitro susceptibility to 7 antibiotics of Neisseria meningitidis strains isolated last years in Romania.
    Pană M; Ghiţă M; Levenet I; Nica M; Botea S; Osz T
    Roum Arch Microbiol Immunol; 2009; 68(1):38-43. PubMed ID: 19507626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multilaboratory evaluation of disk diffusion antimicrobial susceptibility testing of Neisseria meningitidis isolates.
    Jorgensen JH; Crawford SA; Fulcher LC; Glennen A; Harrington SM; Swenson J; Lynfield R; Murray PR; Tenover FC
    J Clin Microbiol; 2006 May; 44(5):1744-54. PubMed ID: 16672402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of Neisseria meningitidis to 16 antimicrobial agents and characterization of resistance mechanisms affecting some agents.
    Jorgensen JH; Crawford SA; Fiebelkorn KR
    J Clin Microbiol; 2005 Jul; 43(7):3162-71. PubMed ID: 16000430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of ciprofloxacin- and penicillin-resistant
    Takahashi H; Morita M; Kamiya H; Fukusumi M; Yasuda M; Sunagawa M; Nakamura-Miwa H; Ohama Y; Shimuta K; Ohnishi M; Saito R; Akeda Y
    Antimicrob Agents Chemother; 2023 Nov; 67(11):e0074423. PubMed ID: 37874301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates.
    Farrell DJ; Sader HS; Castanheira M; Biedenbach DJ; Rhomberg PR; Jones RN
    Int J Antimicrob Agents; 2010 Jun; 35(6):537-43. PubMed ID: 20211548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
    Kosowska K; Credito K; Pankuch GA; Hoellman D; Lin G; Clark C; Dewasse B; McGhee P; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4113-9. PubMed ID: 15504829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of cethromycin (ABT-773), a new ketolide, against Streptococcus pneumoniae strains that are not susceptible to penicillin or macrolides.
    Mason EO; Lamberth LB; Wald ER; Bradley JS; Barson WJ; Kaplan SL
    Antimicrob Agents Chemother; 2003 Jan; 47(1):166-9. PubMed ID: 12499186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents.
    Ednie LM; Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 May; 41(5):1033-6. PubMed ID: 9145864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial Susceptibility Survey of Invasive Neisseria meningitidis, United States 2012-2016.
    Potts CC; Rodriguez-Rivera LD; Retchless AC; Hu F; Marjuki H; Blain AE; McNamara LA; Wang X
    J Infect Dis; 2022 Jun; 225(11):1871-1875. PubMed ID: 35266516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria.
    Putnam SD; Castanheira M; Moet GJ; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):393-401. PubMed ID: 20022192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of penicillin-sensitive and penicillin-resistant meningococci.
    Abadi FJ; Yakubu DE; Pennington TH
    J Antimicrob Chemother; 1995 May; 35(5):687-90. PubMed ID: 7592183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of antimicrobial resistance in Neisseria meningitidis strains isolated from invasive cases in Brazil from 2009 to 2016.
    Gorla MC; Pinhata JMW; Dias UJ; de Moraes C; Lemos AP
    J Med Microbiol; 2018 Jun; 67(6):750-756. PubMed ID: 29717974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Have South Australian isolates of Neisseria meningitidis become less susceptible to penicillin, rifampicin and other drugs? A study of strains isolated over three decades, 1971-1999.
    Hansman D; Wati S; Lawrence A; Turnidge J
    Pathology; 2004 Apr; 36(2):160-5. PubMed ID: 15203752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of oral telithromycin in foals and in vitro activity of the drug against macrolide-susceptible and macrolide-resistant Rhodococcus equi isolates.
    Javsicas LH; Giguère S; Womble AY
    J Vet Pharmacol Ther; 2010 Aug; 33(4):383-8. PubMed ID: 20646201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penicillin- and Ciprofloxacin-Resistant Invasive Neisseria meningitidis Isolates from Japan.
    Saito R; Nakajima J; Prah I; Morita M; Mahazu S; Ota Y; Kobayashi A; Tohda S; Kamiya H; Takahashi H; Ohnishi M
    Microbiol Spectr; 2022 Jun; 10(3):e0062722. PubMed ID: 35467371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.